The future of pharma pricing, reimbursement and market access

27 June 2016
europe-us-large

By Dr Nicola Davies

One thing is certain: the payer landscape is changing. However, the best way for industry players to respond to the changes remains unclear. The 2nd Annual Pharma Pricing, Reimbursement and Market Access 2016, held in London, brought together pharmaceutical, biotechnology, health insurance, managed care, public policy and regulatory professionals and experts.

The event provided an overview of the pricing, market access, reimbursement and cost management issues and trends in global pharma. Although the focus of the policy reforms discussed at the conference was in the European Union region, the trends, challenges and key insights shared by speakers were highly applicable to FDA activities.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical